The International Partnership for Microbicides (IPM) 2017 annual report takes a look at promising woman-centered technologies that could expand women's prevention options and help empower them to protect their sexual and reproductive health on their own terms.
Microbicides
Resource
September 11, 2018
Opportunity
August 24, 2018
The HIV Prevention Research Advocacy Fellows Program pairs emerging leaders in advocacy and activism with existing organizations to develop and execute creative, context-specific projects focused on HIV prevention research.
Resource
February 19, 2018
Written in plain terms and organized for quick review, the popular Family Planning: A Global Handbook for Providers offers clinic-based health care professionals in low- and middle-income countries the latest guidance on providing contraceptive methods. Updated to include expanded contra
Resource
July 25, 2017
To mark the 9th IAS Conference on HIV Science, the Lancet journals have made a selection of content free that reflects some of the breadth and diversity of clinical, epidemiological, and operational HIV research produced by the tireless global HIV community.
Resource
June 26, 2017
Topical prevention of HIV and other STIs is a global health priority. To provide options for users, developers have worked to design safe, effective and acceptable vaginal dissolving film formulations.
Resource
June 19, 2017
Women globally need access to multipurpose prevention technologies (MPTs) that prevent human immunodeficiency virus (HIV), sexually transmitted infections that increase HIV acquisition/transmission risk, and unintended pregnancy.
Resource
December 6, 2016
For persons at risk of HIV infection who practice receptive anal intercourse (RAI), topical rectal microbicides represent a promising option for coitally-dependent protection.
Resource
December 5, 2016
Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence.
Resource
November 30, 2016
Under the Preventive Technologies Agreement supported by the US Agency for International Development, FHI 360 implemented two projects designed to increase understanding of the gender issues likely to affect women’s microbicide use.
